An estimated 5% to 10% of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need for ...

Owing to the propensity for visual loss, immunosuppressive treatment in the form of systemic and/or local therapy is often required for the management of noninfective intermediate and posterior ...

An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...

A 61-year-old woman presented with a 3-month history of floaters and decreased vision in her left eye. Her visual acuity was 6/7.5 and 6/18 in the right eye and left eye, respectively. Dilated ...

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that ...

Please provide your email address to receive an email when new articles are posted on . Individually tailored immunosuppressive therapy may help preserve vision in at least one eye in children with ...

Expert Rev Ophthalmol. 2012;7(6):587-594. Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations ...

A professor and the chairman of the Department of Ophthalmology at Mount Sinai, Jabs has specialized in treating uveitis for 25 years. Who’s at risk Uveitis is an inflammatory process that affects the ...

Please provide your email address to receive an email when new articles are posted on . Uveitis describes inflammation that exists in the uveal tract, but the disease course has such a variety of ...

Results from a recent study support prior findings of the association between MS and uveitis. A diagnosis of uveitis conferred a significantly higher risk of subsequent or coincident MS and a vast ...